Culture Biosciences develops automated bio-reactor that helps biotech companies optimize their manufacturing processes and brings products to market faster. The company also builds automated tools for fermentation. It has a digital bio-manufacturing platform to enable scientists to run, monitor, and analyze bio-reactors faster than traditional approaches by robotic sample handling and cloud data monitoring and analysis. Culture Biosciences was founded in 2016 and is headquartered in San Francisco, California.
Leveraging recent discoveries in genomics, precision gene editing, and expression, Ohalo is reimagining the art and science of plant breeding. The company is delivering novel plant species for agriculture that use less land, water, and other resources ...
The EVERY Company is the market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Leveraging advanced fermentation to produce functional and nutritional proteins from microorganisms, the Company is reimagining the factory farm model that underpins industrial animal agriculture with a more sustainable, kinder, and healthier alternative. Clara Foods is on a mission to decouple the world's most powerful proteins from the animals that make them.
We discover the 1 in a million 10,000x faster. Harnessing evolution means giving nature the time and space to find complex solutions. Current technology falls fall short of the scale required to accelerate this process. The current state of the art is to rely on technology like liquid-handling robotics to look for a 1-in-a-million solution using a method that can only search through thousands of samples. At Triplebar, we measure the effect of billions of mutations. We oversample the genome every day and use this capacity to quickly find solutions to the greatest problems we face.
We discover the 1 in a million 10,000x faster. Harnessing evolution means giving nature the time and space to find complex solutions. Current technology falls fall short of the scale required to accelerate this process. The current state of the art is to rely on technology like liquid-handling robotics to look for a 1-in-a-million solution using a method that can only search through thousands of samples. At Triplebar, we measure the effect of billions of mutations. We oversample the genome every day and use this capacity to quickly find solutions to the greatest problems we face.